Lipocine Inc. (LPCN) insider trading
Lipocine Inc. insiders have made 2 open-market purchases worth $82k since Oct 1, 2026, by 1 insider. The latest: John W. Higuchi (Director) bought $55k, filed Oct 2, 2026, scored 31 out of 100.
Follow LPCN, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 2 Form 4 (opens sec.gov) |
John W. HiguchiDirectorDirector · Near 52-week low | +12% stake | 31 | $55k 25,007 at $2.20 |
−16.1% | waiting |
| Oct 1 Form 4 (opens sec.gov) |
John W. HiguchiDirectorDirector · Near 52-week low | +6% stake | 26 | $27k 12,561 at $2.16 |
−6.8% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −11.4% (0% up, 2 measured).
Insiders who bought LPCN
- John W. Higuchi Director
Questions
Are insiders buying LPCN stock?
Yes. In the last 90 days, 2 open-market purchases were filed, worth $82k.
Who bought LPCN stock most recently?
John W. Higuchi, Director, bought 25,007 shares for $55k (Form 4 (opens sec.gov), filed Oct 2, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer